WHAT IS
MERIVA®
MERIVA® is a patent pending delivery form of curcumin.
Curcumin typically exhibits poor oral absorption in the body.
Pharmacokinetic comparison studies have shown MERIVA® to improve bioavailability of curcuminoids by about 30-fold.
Three studies conducted with MERIVA® demonstrated significant improvements related to stiffness, muscle soreness, physical function, liver health and overall quality of life. A long term study has shown MERIVA® also to support ocular health confirming the inflammatory response markers support and the excellent safety profile.
SPECIFICATIONS
MERIVA® is standardized to contain 18-22% of total curcuminoids.
RECOMMENDED DOSE
MERIVA® is a light orange powder for use in nutritional supplements. Recommended daily dose: 500 mg
SCIENTIFIC EVIDENCE
MERIVA® is overall supported by over 30 human studies, involving 2000+ individuals, confirming its high tolerability profile.
TRADEMARKS
MERIVA® is a trademark of Indena S.p.A. and its logo and usage guidelines are available from Indena.
MERIVA®
Three studies conducted with MERIVA® demonstrated significant improvements related to stiffness, muscle soreness, physical function, liver health and overall quality of life.
WHAT MAKES
MERIVA® UNIQUE?
MERIVA® is the 100% natural food grade delivery form of curcumin utilizing Indena proprietary Phytosome® technology, based on dietary-grade adjuvants (lecithin), able to optimize the bioabsorption of the extract.
MERIVA® is the most studied and documented curcumin bioavailable formulation.
MERIVA® pharmacokinetic studies demonstrated significant absorption benefits.
• Improved plasma Cmax and AUC of curcuminoids near 30-fold over the standard turmeric extracts.
100% natural
MERIVA® is the most studied and documented curcumin bioavailable formulation.
MERIVA® is supported by more than
30* human trials
MERIVA® is supported by more than 30* human trials demonstrating effectiveness for joint & bone health and healthy inflammatory response after exercise and similar exertion:
• Decreased WOMAC score measuring excercise related pain, stiffness and physical function.
• Social and Emotional Index (SEI) score resulted in a greater than 3-fold improvement.
• C-Reactive Protein (CRP) levels decreased by 16-fold.
• Healthy blood vessel function support.
• Attenuated muscle soreness from oxidative stress and inflammation associated to continuous exercise, statistically significant reduction of IL-8 vs placebo and IL-6, reduction of MRI evidence of muscle stress.
• Improved strength and physical performance, preventing loss of lean body mass in elderly population. Improved bone density in asymptomatic subjects with a bone density condition. Improved health status in subjects with non-alcoholic fatty liver disease (NAFLD).
Flexadrin
Flexadrin
Flexadrin
